Concepts (266)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pseudomonas Phages | 2 | 2021 | 11 | 0.950 |
Why?
|
| Sewage | 2 | 2021 | 7 | 0.820 |
Why?
|
| Rivers | 2 | 2021 | 10 | 0.810 |
Why?
|
| beta-Lactamases | 4 | 2020 | 223 | 0.800 |
Why?
|
| Klebsiella Infections | 2 | 2018 | 62 | 0.750 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 3 | 2020 | 214 | 0.620 |
Why?
|
| Embolism | 1 | 2018 | 64 | 0.590 |
Why?
|
| Fluorodeoxyglucose F18 | 3 | 2014 | 1260 | 0.590 |
Why?
|
| Klebsiella pneumoniae | 1 | 2018 | 101 | 0.580 |
Why?
|
| Foreign-Body Migration | 1 | 2018 | 122 | 0.570 |
Why?
|
| Wounds, Gunshot | 1 | 2018 | 150 | 0.550 |
Why?
|
| Iran | 10 | 2024 | 76 | 0.500 |
Why?
|
| Anti-Bacterial Agents | 8 | 2024 | 3187 | 0.490 |
Why?
|
| Positron-Emission Tomography | 3 | 2014 | 2197 | 0.480 |
Why?
|
| Phage Therapy | 3 | 2024 | 25 | 0.460 |
Why?
|
| Cardiac Catheterization | 1 | 2018 | 669 | 0.440 |
Why?
|
| Microbial Sensitivity Tests | 6 | 2024 | 1076 | 0.440 |
Why?
|
| Intensive Care Units | 1 | 2018 | 738 | 0.430 |
Why?
|
| Heart Ventricles | 1 | 2018 | 847 | 0.430 |
Why?
|
| Veins | 1 | 2013 | 163 | 0.420 |
Why?
|
| Microbiota | 3 | 2024 | 547 | 0.410 |
Why?
|
| Endovascular Procedures | 1 | 2018 | 471 | 0.400 |
Why?
|
| Whole Body Imaging | 1 | 2013 | 120 | 0.400 |
Why?
|
| Colistin | 2 | 2022 | 37 | 0.370 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2018 | 7783 | 0.360 |
Why?
|
| Helicobacter pylori | 4 | 2019 | 1436 | 0.360 |
Why?
|
| Multimodal Imaging | 2 | 2014 | 550 | 0.340 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2024 | 430 | 0.340 |
Why?
|
| Pseudomonas Infections | 2 | 2021 | 166 | 0.340 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2021 | 252 | 0.320 |
Why?
|
| Probiotics | 2 | 2023 | 241 | 0.310 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2007 | 322 | 0.260 |
Why?
|
| Alzheimer Disease | 2 | 2024 | 818 | 0.260 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2024 | 980 | 0.260 |
Why?
|
| Integrons | 1 | 2024 | 1 | 0.240 |
Why?
|
| Polymerase Chain Reaction | 3 | 2024 | 3476 | 0.240 |
Why?
|
| Stenotrophomonas maltophilia | 1 | 2024 | 32 | 0.230 |
Why?
|
| Organometallic Compounds | 2 | 2015 | 209 | 0.220 |
Why?
|
| Bacterial Proteins | 4 | 2024 | 1092 | 0.220 |
Why?
|
| Surgical Wound | 1 | 2024 | 49 | 0.220 |
Why?
|
| Nanotubes, Carbon | 1 | 2023 | 30 | 0.210 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2024 | 170 | 0.210 |
Why?
|
| Biosensing Techniques | 1 | 2023 | 76 | 0.210 |
Why?
|
| Cross-Sectional Studies | 8 | 2024 | 4492 | 0.200 |
Why?
|
| Antigens, Bacterial | 2 | 2019 | 372 | 0.200 |
Why?
|
| Complementary Therapies | 1 | 2023 | 120 | 0.190 |
Why?
|
| Host Specificity | 1 | 2021 | 20 | 0.190 |
Why?
|
| Fibroblasts | 1 | 2007 | 1654 | 0.190 |
Why?
|
| Environmental Microbiology | 1 | 2021 | 22 | 0.190 |
Why?
|
| Mouth | 1 | 2022 | 125 | 0.190 |
Why?
|
| Metal Nanoparticles | 1 | 2023 | 161 | 0.180 |
Why?
|
| Tonsillitis | 1 | 2020 | 17 | 0.180 |
Why?
|
| Lactobacillus plantarum | 1 | 2020 | 5 | 0.180 |
Why?
|
| Palatine Tonsil | 1 | 2020 | 61 | 0.180 |
Why?
|
| Genome, Viral | 1 | 2021 | 189 | 0.180 |
Why?
|
| Helicobacter Infections | 3 | 2019 | 1353 | 0.180 |
Why?
|
| Mesenteric Ischemia | 1 | 2020 | 13 | 0.180 |
Why?
|
| Burns | 1 | 2021 | 130 | 0.180 |
Why?
|
| Bone Neoplasms | 1 | 2013 | 2665 | 0.170 |
Why?
|
| Bacterial Infections | 1 | 2024 | 510 | 0.170 |
Why?
|
| Mesentery | 1 | 2020 | 74 | 0.170 |
Why?
|
| Acinetobacter Infections | 1 | 2020 | 29 | 0.170 |
Why?
|
| Radial Artery | 1 | 2019 | 35 | 0.170 |
Why?
|
| Embolization, Therapeutic | 2 | 2019 | 605 | 0.170 |
Why?
|
| Acinetobacter baumannii | 1 | 2020 | 54 | 0.170 |
Why?
|
| Mesenteric Veins | 1 | 2020 | 83 | 0.170 |
Why?
|
| Oxazolidinones | 1 | 2019 | 63 | 0.160 |
Why?
|
| Tetrazoles | 1 | 2019 | 96 | 0.160 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 212 | 0.160 |
Why?
|
| Femoral Artery | 1 | 2019 | 197 | 0.160 |
Why?
|
| Nalidixic Acid | 1 | 2018 | 3 | 0.160 |
Why?
|
| Recombination, Genetic | 1 | 2021 | 665 | 0.160 |
Why?
|
| Clavulanic Acid | 1 | 2018 | 10 | 0.160 |
Why?
|
| Adhesins, Bacterial | 1 | 2019 | 82 | 0.160 |
Why?
|
| Venous Cutdown | 1 | 2018 | 3 | 0.160 |
Why?
|
| Imipenem | 1 | 2018 | 28 | 0.160 |
Why?
|
| Klebsiella | 1 | 2018 | 10 | 0.160 |
Why?
|
| Stomach Diseases | 1 | 2019 | 72 | 0.150 |
Why?
|
| Nervous System Diseases | 1 | 2023 | 517 | 0.150 |
Why?
|
| Leiomyoma | 1 | 2019 | 161 | 0.150 |
Why?
|
| Humans | 37 | 2024 | 270740 | 0.150 |
Why?
|
| Anti-Infective Agents | 1 | 2022 | 466 | 0.150 |
Why?
|
| Staphylococcus aureus | 2 | 2020 | 562 | 0.150 |
Why?
|
| Femoral Vein | 1 | 2018 | 63 | 0.150 |
Why?
|
| Computed Tomography Angiography | 1 | 2020 | 247 | 0.150 |
Why?
|
| Catheterization, Peripheral | 1 | 2019 | 153 | 0.150 |
Why?
|
| Interleukin-17 | 1 | 2019 | 255 | 0.150 |
Why?
|
| beta-Lactamase Inhibitors | 1 | 2018 | 62 | 0.150 |
Why?
|
| Amoxicillin | 1 | 2018 | 123 | 0.150 |
Why?
|
| Molecular Epidemiology | 1 | 2018 | 247 | 0.140 |
Why?
|
| Colitis | 1 | 2020 | 341 | 0.140 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2019 | 291 | 0.130 |
Why?
|
| Staphylococcal Infections | 2 | 2019 | 678 | 0.130 |
Why?
|
| Germanium | 1 | 2015 | 7 | 0.130 |
Why?
|
| Radiochemistry | 1 | 2015 | 8 | 0.130 |
Why?
|
| Tertiary Care Centers | 1 | 2018 | 417 | 0.130 |
Why?
|
| Adjuvants, Immunologic | 1 | 2019 | 695 | 0.130 |
Why?
|
| Mental Disorders | 1 | 2023 | 882 | 0.120 |
Why?
|
| Stomach Neoplasms | 1 | 2007 | 2331 | 0.120 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2019 | 714 | 0.120 |
Why?
|
| Uterine Neoplasms | 1 | 2019 | 576 | 0.120 |
Why?
|
| Escherichia coli | 2 | 2023 | 1305 | 0.120 |
Why?
|
| Radioisotopes | 1 | 2015 | 178 | 0.120 |
Why?
|
| DNA, Bacterial | 2 | 2020 | 607 | 0.120 |
Why?
|
| Male | 19 | 2024 | 128315 | 0.120 |
Why?
|
| Bacteria | 3 | 2024 | 654 | 0.120 |
Why?
|
| Plasmids | 1 | 2016 | 936 | 0.120 |
Why?
|
| Adult | 16 | 2022 | 82040 | 0.110 |
Why?
|
| Saliva | 2 | 2005 | 238 | 0.110 |
Why?
|
| Receptors, Somatostatin | 1 | 2014 | 94 | 0.110 |
Why?
|
| Digestive System Neoplasms | 1 | 2014 | 79 | 0.110 |
Why?
|
| Phlebography | 1 | 2013 | 67 | 0.110 |
Why?
|
| Epidermal Growth Factor | 2 | 2005 | 439 | 0.110 |
Why?
|
| Octreotide | 1 | 2014 | 131 | 0.110 |
Why?
|
| Contrast Media | 1 | 2020 | 1499 | 0.110 |
Why?
|
| Apoptosis | 1 | 2007 | 7757 | 0.110 |
Why?
|
| Pandemics | 1 | 2022 | 1610 | 0.110 |
Why?
|
| Genetic Variation | 1 | 2021 | 2166 | 0.110 |
Why?
|
| Prevalence | 4 | 2024 | 3404 | 0.100 |
Why?
|
| Nasal Polyps | 1 | 2011 | 29 | 0.100 |
Why?
|
| Urease | 1 | 2011 | 78 | 0.100 |
Why?
|
| Middle Aged | 16 | 2020 | 90352 | 0.100 |
Why?
|
| Nitric Oxide | 2 | 2005 | 658 | 0.100 |
Why?
|
| Nasal Mucosa | 1 | 2011 | 84 | 0.090 |
Why?
|
| Radiation Dosage | 1 | 2015 | 1042 | 0.090 |
Why?
|
| Aged | 10 | 2024 | 73333 | 0.090 |
Why?
|
| Female | 19 | 2020 | 148940 | 0.090 |
Why?
|
| Adenocarcinoma | 1 | 2007 | 7914 | 0.080 |
Why?
|
| Cystic Duct | 1 | 2008 | 9 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2013 | 4831 | 0.080 |
Why?
|
| Oxidative Stress | 2 | 2005 | 1149 | 0.080 |
Why?
|
| Phylogeny | 2 | 2021 | 867 | 0.080 |
Why?
|
| Radiopharmaceuticals | 1 | 2014 | 1341 | 0.080 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2008 | 75 | 0.080 |
Why?
|
| Densitometry | 1 | 2007 | 51 | 0.080 |
Why?
|
| Neuroendocrine Tumors | 1 | 2014 | 656 | 0.070 |
Why?
|
| Neoplasms | 1 | 2013 | 15927 | 0.070 |
Why?
|
| Adolescent | 5 | 2020 | 32767 | 0.070 |
Why?
|
| Olfaction Disorders | 1 | 2006 | 31 | 0.070 |
Why?
|
| Thyroid Diseases | 1 | 2007 | 85 | 0.070 |
Why?
|
| Genes, Recessive | 1 | 2007 | 205 | 0.070 |
Why?
|
| Species Specificity | 1 | 2007 | 794 | 0.070 |
Why?
|
| Calcium Phosphates | 1 | 2006 | 15 | 0.070 |
Why?
|
| Urinary Calculi | 1 | 2006 | 29 | 0.070 |
Why?
|
| Immunoblotting | 1 | 2007 | 895 | 0.070 |
Why?
|
| Calcium Oxalate | 1 | 2006 | 28 | 0.070 |
Why?
|
| Case-Control Studies | 4 | 2022 | 6224 | 0.060 |
Why?
|
| Treatment Outcome | 5 | 2020 | 33737 | 0.060 |
Why?
|
| Pentoxifylline | 1 | 2005 | 38 | 0.060 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2007 | 154 | 0.060 |
Why?
|
| Proteinuria | 1 | 2006 | 155 | 0.060 |
Why?
|
| Craniocerebral Trauma | 1 | 2006 | 154 | 0.060 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2006 | 334 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2005 | 1412 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2013 | 7895 | 0.060 |
Why?
|
| Allopurinol | 1 | 2004 | 85 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 30998 | 0.060 |
Why?
|
| Risk | 1 | 2007 | 1939 | 0.050 |
Why?
|
| Electrochemical Techniques | 1 | 2023 | 8 | 0.050 |
Why?
|
| Genes, Bacterial | 1 | 2024 | 270 | 0.050 |
Why?
|
| Aggregatibacter actinomycetemcomitans | 1 | 2022 | 4 | 0.050 |
Why?
|
| Bone Density | 1 | 2005 | 466 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2013 | 9292 | 0.050 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2022 | 66 | 0.050 |
Why?
|
| Antioxidants | 1 | 2005 | 521 | 0.050 |
Why?
|
| Laboratories | 1 | 2023 | 132 | 0.050 |
Why?
|
| Acetaminophen | 1 | 2023 | 125 | 0.050 |
Why?
|
| Child, Preschool | 1 | 2018 | 17061 | 0.050 |
Why?
|
| Pharmaceutical Preparations | 1 | 2023 | 152 | 0.050 |
Why?
|
| Gold | 1 | 2023 | 267 | 0.050 |
Why?
|
| Genotyping Techniques | 1 | 2021 | 164 | 0.050 |
Why?
|
| Dextran Sulfate | 1 | 2020 | 69 | 0.040 |
Why?
|
| Colony Count, Microbial | 1 | 2020 | 159 | 0.040 |
Why?
|
| Disease Outbreaks | 1 | 2023 | 405 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 3-gamma | 1 | 2019 | 5 | 0.040 |
Why?
|
| Surgical Wound Infection | 1 | 2024 | 495 | 0.040 |
Why?
|
| Child | 2 | 2018 | 30559 | 0.040 |
Why?
|
| Carbapenems | 1 | 2020 | 63 | 0.040 |
Why?
|
| Punctures | 1 | 2019 | 102 | 0.040 |
Why?
|
| Interleukin-18 | 1 | 2019 | 91 | 0.040 |
Why?
|
| Coinfection | 1 | 2021 | 200 | 0.040 |
Why?
|
| Bacteriological Techniques | 1 | 2020 | 123 | 0.040 |
Why?
|
| Young Adult | 4 | 2020 | 22251 | 0.040 |
Why?
|
| Interleukin-4 | 1 | 2019 | 290 | 0.040 |
Why?
|
| Superantigens | 1 | 2018 | 32 | 0.040 |
Why?
|
| Body Height | 1 | 2019 | 234 | 0.040 |
Why?
|
| Haplotypes | 1 | 2021 | 910 | 0.040 |
Why?
|
| Th2 Cells | 1 | 2019 | 252 | 0.040 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2018 | 42 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2021 | 730 | 0.040 |
Why?
|
| Enterotoxins | 1 | 2018 | 122 | 0.040 |
Why?
|
| Th1 Cells | 1 | 2019 | 259 | 0.040 |
Why?
|
| Th17 Cells | 1 | 2019 | 163 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2013 | 14012 | 0.040 |
Why?
|
| Biopsy | 2 | 2019 | 3484 | 0.040 |
Why?
|
| Virulence | 1 | 2019 | 352 | 0.040 |
Why?
|
| Mutation | 3 | 2023 | 15912 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2005 | 848 | 0.040 |
Why?
|
| Interleukin-8 | 1 | 2019 | 531 | 0.040 |
Why?
|
| Interleukins | 1 | 2019 | 341 | 0.040 |
Why?
|
| Bacterial Toxins | 1 | 2018 | 229 | 0.040 |
Why?
|
| Evolution, Molecular | 1 | 2021 | 867 | 0.030 |
Why?
|
| Colon | 1 | 2020 | 659 | 0.030 |
Why?
|
| Time Factors | 3 | 2019 | 13006 | 0.030 |
Why?
|
| Ion Exchange | 1 | 2015 | 9 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 2019 | 889 | 0.030 |
Why?
|
| Chemistry Techniques, Synthetic | 1 | 2015 | 10 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2013 | 5574 | 0.030 |
Why?
|
| Stomach | 1 | 2019 | 402 | 0.030 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 2 | 2005 | 17 | 0.030 |
Why?
|
| Genotype | 2 | 2019 | 4252 | 0.030 |
Why?
|
| Melanoma | 1 | 2013 | 5595 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2022 | 2828 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2019 | 1129 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2020 | 2454 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2021 | 1570 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2019 | 1179 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2020 | 1824 | 0.030 |
Why?
|
| Lipid Peroxidation | 2 | 2005 | 164 | 0.030 |
Why?
|
| Vaccines | 1 | 2019 | 399 | 0.030 |
Why?
|
| Respiratory Tract Infections | 1 | 2018 | 408 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 3028 | 0.030 |
Why?
|
| Escherichia coli Infections | 1 | 2016 | 272 | 0.030 |
Why?
|
| Brain | 1 | 2006 | 4208 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2008 | 5681 | 0.030 |
Why?
|
| Cytokines | 1 | 2022 | 2825 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2020 | 39890 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 6177 | 0.030 |
Why?
|
| Bacteremia | 1 | 2018 | 721 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 14849 | 0.030 |
Why?
|
| Animals | 3 | 2024 | 61956 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2013 | 12033 | 0.020 |
Why?
|
| Neoplasm Grading | 1 | 2014 | 1823 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2005 | 2580 | 0.020 |
Why?
|
| Sphincterotomy, Endoscopic | 1 | 2008 | 18 | 0.020 |
Why?
|
| Cholangiography | 1 | 2008 | 34 | 0.020 |
Why?
|
| Cholelithiasis | 1 | 2008 | 49 | 0.020 |
Why?
|
| Mice | 2 | 2020 | 35600 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 7381 | 0.020 |
Why?
|
| Vestibule, Labyrinth | 1 | 2007 | 44 | 0.020 |
Why?
|
| Thyroxine | 1 | 2007 | 114 | 0.020 |
Why?
|
| Sulfonylurea Compounds | 1 | 2005 | 32 | 0.020 |
Why?
|
| Free Radical Scavengers | 1 | 2005 | 82 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 4960 | 0.020 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2005 | 81 | 0.020 |
Why?
|
| Femur | 1 | 2005 | 161 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6256 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2011 | 15218 | 0.010 |
Why?
|
| Postmenopause | 1 | 2005 | 375 | 0.010 |
Why?
|
| Syndrome | 1 | 2007 | 1407 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2011 | 5694 | 0.010 |
Why?
|
| Reference Values | 1 | 2005 | 1133 | 0.010 |
Why?
|
| Osteoporosis | 1 | 2005 | 232 | 0.010 |
Why?
|
| Texas | 1 | 2014 | 6449 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2005 | 425 | 0.010 |
Why?
|
| Disease Progression | 1 | 2014 | 6867 | 0.010 |
Why?
|
| Risk Factors | 1 | 2019 | 17888 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2004 | 1312 | 0.010 |
Why?
|
| Incidence | 1 | 2011 | 5824 | 0.010 |
Why?
|
| Metformin | 1 | 2005 | 393 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2005 | 599 | 0.010 |
Why?
|
| Quality of Life | 1 | 2014 | 4761 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 2007 | 2035 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2005 | 2232 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 4372 | 0.010 |
Why?
|
| Prognosis | 1 | 2005 | 22505 | 0.000 |
Why?
|